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In response to the question raised by Prof. Al-
endalawi about rotavirus immunization coverage
n Lebanon, we would like to emphasize that the
otavirus vaccine is not incorporated in the routine
mmunization schedule; the vaccine is however
vailable in the private clinics. Unfortunately, the
nti-rotavirus immunity of patients included in our
tudy has not been investigated. Our results are not
ifferent from those obtained in Europe. In France
here rotavirus vaccination is not included in the
outine immunization program, a recent study has
eported that rotavirus was the cause of more than
0% of the total hospitalizations for gastroenteritis
er year in a pediatric unit in Paris, followed by
orovirus causing 8% of the total hospitalizations
1].
Despite the availability of rotavirus vaccine in
everal private clinics of North Lebanon, rotavirus
ontinues to cause severe acute gastroenteritis
n infants and young children. These observations
ighlight the need to launch community awareness
ampaigns, and to integrate the rotavirus vac-
ine in the routine immunization program [2]. It
as been speculated that the reduction in acute
astroenteritis outcomes may be seen primarily
n infants younger than 1 year in the ﬁrst year
f vaccine introduction, in those younger than 2
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oi:10.1016/j.jiph.2011.09.002ears in the second year of the rotavirus vaccina-
ion program, and in incrementally increasing age
roups during successive years [3]. Efforts should be
herefore made in order to integrate the rotavirus
accine in the routine immunization schedule, and
o incorporate routine screening tests for norovirus
n hospitals and other clinical settings.
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